Theraclone Sciences Obtains $3,080,000 New Round

  • Feed Type
  • Date
    5/8/2015
  • Company Name
    Theraclone Sciences
  • Mailing Address
    1124 Columbia Street Seattle, WA 98104 USA
  • Company Description
    Theraclone Sciences is a discovery-stage biotech developing novel therapeutic antibodies for the treatment of infectious disease and inflammation. Our proprietary discovery platform allows us to comprehensively screen and identify the rare antibodies that select individuals produce to successfully ward off disease.
  • Website
    http://www.theraclone-sciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,080,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor